Market Overview

UPDATE: Morgan Stanley Initiates LifePoint Hospitals at Equal-Weight on Risk/Reward

Share:
Related LPNT
Goldman Removes Lifepoint From Buy List, Downgrades To Neutral
The Top 20 Wall Street Analysts Of 2015

Morgan Stanley initiated LifePoint Hospitals (NASDAQ: LPNT) with an Equal-weight rating.

Morgan Stanley commented, "LifePoint is the purest play on the rural market. Therefore, we think LPNT will be able to maintain better commercial pricing including in the exchanges. However, LPNT is experiencing weaker utilization statistics with a slower rebound. Lowest financial leverage will decrease opportunity on the upside if multiples expand but will help finance strong acquisition pipeline."

LifePoint Hospitals closed at $41.68 on Wednesday.

Latest Ratings for LPNT

DateFirmActionFromTo
Jan 2016Goldman SachsDowngradesNeutralBuy
Jan 2016Raymond JamesUpgradesMarket PerformOutperform
Jan 2016BarclaysMaintainsUnderweight

View More Analyst Ratings for LPNT
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (LPNT)

Get Benzinga's Newsletters